Clinical trial
Memory Functioning and Antidepressant Treatment
NCT00296933 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00296933 |
|---|---|
| Title | Memory Functioning and Antidepressant Treatment |
| Official title | Memory Functioning and Antidepressant Treatment: A Randomized Controlled Trial Comparing Escitalopram and Bupropion XL |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | GlaxoSmithKline Industry H. Lundbeck A/S |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Escitalopram, Bupropion XL |
| Enrollment | 60 |
| Start date | Dec 1, 2005 |
| First posted | Feb 27, 2006 |
| Last update posted | Feb 17, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: